Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
Thalassemia is a disease of erythrocytes that varies largely on its genetic composition and associated clinical presentation. Though some patients may remain asymptomatic, those with a complicated course may experience severe anemia early in childhood, carrying into adulthood and requiring recurrent...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2022-09-01
|
| Schriftenreihe: | Thalassemia Reports |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2039-4365/12/3/17 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
